Microbiological Diagnosis Using Bronchoscopy In Patients With Bronchiectasis: Comparison Between Techniques And Association With Patient Characteristics.

Authors:

Abstract
Accurate microbiological diagnosis in bronchiectasis allows optimisation of treatment and infection control. Bronchoscopy may be useful in selected cases. Aims: To assess the diagnostic yield of bronchoscopy and sample types (BAS and BAL), identify frequent pathogens, and examine patient characteristics associated with these pathogens. Methods: Retrospective analysis of microbiological results from 160 bronchoscopies performed in 80 patients over 10 years. Results: We analysed 160 bronchoscopies (144 BAS, 140 BAL) in 80 CT‑confirmed bronchiectasis patients. Most were female (77.5%), mean age 64.5±12.6 years, BMI 23±4.1 kg/m². Forty per cent were smokers or former smokers, and 39.7% had airflow-limitation. Bronchiectasis was multilobar in 86.3% and bilateral in 78.8%. Pathogens were identified in 83.3%, mainly Mycobacteria (27.5%), Haemophilus spp. (18.7%), Pseudomonas spp. (13.1%), Staphylococcus aureus (8.1%) and Nocardia spp. (7.5%). Aspergillus spp. were detected in 51 cases. BAL showed higher yield for fungi; 38 pathogens were positive in only one sample type. In multivariate analysis, lower BMI was associated with Mycobacteria (p=0.041); older age and higher BMI with Staphylococcus aureus (p=0.001, p=0.05); airflow limitation with Pseudomonas spp. (p=0.05); smoking status with Nocardia spp. (p=0.024); and younger age with Haemophilus spp. (p=0.05). Conclusions: Bronchoscopy achieved an 83.8% diagnostic yield, with a notable proportion of Mycobacteria. BAS and BAL provide complementary information; collection of both is advisable. Several patient characteristics correlate with specific pathogens, particularly lower BMI with Mycobacteria and older age with Staphylococcus aureus.